Systagenix Wound Management Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 800

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

  • Investments
  • 1

Systagenix Wound Management General Information

Description

Manufacturer of advanced wound care and general wound care products. The company's products include advanced wound care brands and a portfolio of general wound care products.

Contact Information

Formerly Known As
Johnson & Johnson (Professional Wound Care Unit), Professional Wound Care Business of Ethicon
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Two City Place
  • Beehive Ring Road, Gatwick Airport
  • Crawley RH6 0PA
  • England, United Kingdom
+44 01293
Primary Industry
Other Commercial Services
Other Industries
Medical Supplies
Acquirer
Vertical(s)
Corporate Office
  • Two City Place
  • Beehive Ring Road, Gatwick Airport
  • Crawley RH6 0PA
  • England, United Kingdom
+44 01293

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Systagenix Wound Management Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Systagenix Wound Management‘s full profile, request access.

Request a free trial

Systagenix Wound Management Patents

Systagenix Wound Management Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022096971-A1 Moisture transporting dressing with pressure indicating pad Inactive 03-Nov-2020
WO-2021165826-A1 Self-healing silicone drape Inactive 18-Feb-2020
WO-2021148851-A1 Bio-resorbable wound filler for deep tissue wound closure Inactive 21-Jan-2020
US-20230097410-A1 Wound dressings with acid-induced growth factor release Pending 07-Jan-2020
WO-2021140465-A1 Wound dressings with acid-induced growth factor release Inactive 07-Jan-2020 A61L26/0066
To view Systagenix Wound Management’s complete patent history, request access »

Systagenix Wound Management Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Systagenix Wound Management Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Systagenix Wound Management‘s full profile, request access.

Request a free trial

Systagenix Wound Management Investments (1)

Systagenix Wound Management’s most recent deal was a Buyout/LBO with O2 Insights. The deal was made on 12-Jun-2012.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
O2 Insights 12-Jun-2012 Buyout/LBO Diagnostic Equipment
To view Systagenix Wound Management’s complete investments history, request access »

Systagenix Wound Management FAQs

  • When was Systagenix Wound Management founded?

    Systagenix Wound Management was founded in 2008.

  • Where is Systagenix Wound Management headquartered?

    Systagenix Wound Management is headquartered in Crawley, United Kingdom.

  • What is the size of Systagenix Wound Management?

    Systagenix Wound Management has 800 total employees.

  • What industry is Systagenix Wound Management in?

    Systagenix Wound Management’s primary industry is Other Commercial Services.

  • Is Systagenix Wound Management a private or public company?

    Systagenix Wound Management is a Private company.

  • What is the current valuation of Systagenix Wound Management?

    The current valuation of Systagenix Wound Management is .

  • What is Systagenix Wound Management’s current revenue?

    The current revenue for Systagenix Wound Management is .

  • Who are Systagenix Wound Management’s investors?

    Johnson & Johnson and One Equity Partners have invested in Systagenix Wound Management.

  • When was Systagenix Wound Management acquired?

    Systagenix Wound Management was acquired on 28-Oct-2013.

  • Who acquired Systagenix Wound Management?

    Systagenix Wound Management was acquired by Kinetic Concepts.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process